In today’s increasingly collaborative healthcare ecosystem, effective partnerships and meaningful program support are more than operational niceties—they’re strategic imperatives. Archo.io’s 2024–2025 industry review pulls back the curtain on which companies are leading the way, how stakeholders perceive their contributions, and where unmet needs present future growth opportunities. Table of Contents…

The pharmaceutical industry has long touted patient-centricity as a core principle. However, beneath the rhetoric lies a stark reality: patient engagement metrics remain woefully underdeveloped, underfunded, and underprioritized. Despite the lip service paid to patient-centered approaches, the industry’s actions reveal a different story. In this article, we’ll explore why patient…

Cell and gene therapies (CGT) represent some of the most groundbreaking advancements in modern medicine. With the potential to treat—and in some cases cure—genetic and rare diseases, these therapies are not just medical innovations; they’re paradigm shifts. However, launching a CGT product is far from straightforward. The scientific innovation behind…

Trust is the foundation of every meaningful healthcare interaction—yet it’s one of the hardest things to build and the easiest to break. Today, healthcare systems face a trust deficit. Communities of color, people with disabilities, LGBTQ+ individuals, and those with chronic illnesses often feel unheard, dismissed, or even harmed by…

Patient inclusion is no longer optional—it’s essential. But far too often, patient voices are invited to the table only as a formality. Real change happens not when patients are simply present, but when they are equal partners in decision-making. At Archo Advocacy, we believe it’s time to move beyond tokenism…

Amplify Your Advocacy Voice – Introducing “Bridging the Gap” White Paper Table of Contents In the evolving landscape of patient advocacy, professionals often find themselves navigating complex systems with constrained resources, limited internal support, and regulatory hurdles. What if there was a resource that could articulate the challenges you face…